Genital warts are one of the most commonly reported sexually transmitted diseases
worldwide. A variety of treatment options are available but few have been assessed in large …

This guideline is an update of the 2011 European Guideline for the Management of
Anogenital Warts. It is intended to support best practice in the care of patients with …

Study design This was a Phase IIIb, open-label, randomized, 3-armed, multicenter trial
conducted at 60 study sites in Germany over a period of 21 months in 2001/2002. Participant …

In a double-blind trial, 0· 5% podofilox (podophyllotoxin) or placebo was applied by patients
to their own genital warts in up to four treatment cycles. At some time during the study, 25 of …

OBJECTIVES--The primary objective was to determine if six weeks treatment with
subcutaneous interferon alpha-2a (IFN) and podophyllin 25% W/V administered twice per …

Genital warts are usually asymptomatic, and rarely cause discomfort. Once the patient is
aware of them the main symptom is their cosmetic appearance and resultant psychological …

Objective: The purpose of this double-blind, placebo-controlled study was to evaluate the
safety, clinical efficacy and tole-rability of imiquimod (2%) in cream to cure external genital …

Background: The incidence of overt genital warts, a common sexually transmitted disease of
high prevalence, has been on the rise for the last few years. The infection is caused by …

The objective of the study was to determine the cost implications of patterns of treatment for
patients with external genital warts. A retrospective case note review was carried out at six …

The complete treatment of anogenital warts has not been obtained with any combination of
methods; therefore, new methods are still under investigation. In this study the activity and …